3 enrolling by invitation. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Enrolling by invitation 3 |
Follow Nephritis: new trials by email Literature Review of Nephritis trials Research Report on Nephritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of KITE-363 in Participants With Refractory Autoimmune Diseases KITE-363, Fludarabine, Cyclophosphamide - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 1 | Enrolling by invitation | Kite, A Gilead Company | 52 | 2025-07-02 | 2026-09-28 |
| A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease ADI-001, Fludarabine, Cyclophosphamide - Lupus Nephritis, Autoimmune Diseases | Phase 1 | Enrolling by invitation | Adicet Therapeutics | 180 | 2024-11-10 | 2026-03-19 |
| A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus NKX019, Cyclophosphamide LD - Systemic Lupus Erythematosus | Phase 1 | Enrolling by invitation | Hospital for Special Surgery, New York | 6 | 2024-07-01 | 2026-06-22 |
Lupus Erythematosus, Systemic (3) · Lupus Nephritis (3) · Myositis (2) · Scleroderma, Systemic (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Autoimmune Diseases (1) · Stiff-Person Syndrome (1)
Connective Tissue Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Glomerulonephritis (3) · Immune System Diseases (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Skin and Connective Tissue Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Autoimmune Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2)
Cyclophosphamide (3) · fludarabine (2)
Adicet Therapeutics (1) · Hospital for Special Surgery, New York (1) · Kite, A Gilead Company (1)
United States (3) · Australia (1) · Canada (1) · South Korea (1)